9.50 am : India registers 15,223 new cases on Thursday, taking the overall count to 1,06,10,883. The country’s toll rises by 151 to 1,52,86...
9.50 am: India registers 15,223 new cases on Thursday, taking the overall count to 1,06,10,883. The country’s toll rises by 151 to 1,52,869. India’s active cases stand at 1,92,308, below 2 lakh after nearly seven months, while the number of recoveries reach 1,02,65,706.
9.40 am: Mutant variants of the coronavirus found in South Africa and Brazil could trigger more re-infections, and even reduce vaccine efficacy, though more tests are underway, say experts, according to the Hindustan Times. The new strains emerging in these countries are different from the one reported in the United Kingdom, scientists say.
“It is possible that these mutations and others that emerge in individuals with suboptimal or waning immunity will erode the effectiveness of natural- and vaccine-elicited immunity,” says a team led by researchers from Rockefeller University in a study submitted to Biorxiv on January 19. “The data suggests that Sars-CoV-2 vaccines may need to be updated.”
9.35 am: Recipients of the locally produced Covaxin will be monitored for three months after getting the second dose for any adverse reactions, the Hindustan Times reports, quoting a detailed plan released by the Indian Council of Medical Research. This would be done to dispel safety concerns about the vaccine whose efficacy data is not publicly known.
If a serious adverse event is linked to...
